Nature is the first time a study published in structural and molecular biology when researchers have shown evidence that a single drug, which is already licensed for medical use, can stabilize almost all mutated versions of a human protein, even if the mutation is in sequence.
Single drug provides first evidence of 'nearly universal' pharmacological chaperone for rare disease
